Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Infection
Published in: Infection 5/2009

01-10-2009 | Correspondence

Carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme: Dissemination in Southern Brazil

Authors: A. F. Martins, R. Kuchenbecker, T. Sukiennik, R. Boff, K. C. Reiter, L. Lutz, A. B. M. P. Machado, A. L. Barth

Published in: Infection | Issue 5/2009

Login to get access
Metadata
Title
Carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme: Dissemination in Southern Brazil
Authors
A. F. Martins
R. Kuchenbecker
T. Sukiennik
R. Boff
K. C. Reiter
L. Lutz
A. B. M. P. Machado
A. L. Barth
Publication date
01-10-2009
Publisher
Urban and Vogel
Published in
Infection / Issue 5/2009
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-009-9003-9

Other articles of this Issue 5/2009

Infection 5/2009 Go to the issue

Clinical and Epidemiological Study

Disparities in influenza vaccination coverage rates by target group in five European countries: Trends over seven consecutive seasons

Review

An influenza A H1N1 virus revival – pandemic H1N1/09 virus

Case Report

Femoral osteomyelitis due to Cladophialophora arxii in a patient with chronic granulomatous disease

Clinical and Epidemiological Study

Efficacy and safety of sequential intravenous/oral moxifloxacin vs intravenous/oral amoxicillin/clavulanate for complicated skin and skin structure infections

Case Report

Cutaneous vasculitis associated with fluoroquinolones

Clinical and Epidemiological Study

Continuous vs thrice-daily ceftazidime for elective intravenous antipseudomonal therapy in cystic fibrosis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits